Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MEFFU
- Development stage
- Unknown
- Lead developer
- Triman
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
MEFFU is a brand of combination cold and flu medications developed and marketed by PT. Triman in Indonesia. The product line includes formulations such as MEFFU DMP and MEFFU EXPETORAN, which are designed to alleviate symptoms associated with the common cold and influenza, including fever, headache, nasal congestion, and cough. MEFFU DMP typically contains paracetamol (analgesic/antipyretic), chlorphenamine maleate (antihistamine), phenylephrine HCl (decongestant), and dextromethorphan HBr (antitussive). MEFFU EXPETORAN replaces the antitussive with guaifenesin (expectorant) for productive coughs. These products are classified as branded generics and are approved for over-the-counter or pharmacy sale in the Indonesian market.
- Brand names
- MEFFUMEFFU DMPMEFFU EXPETORAN
02
Targets
HRH1 (Histamine H1 Receptor)SIGMAR1 (Sigma non-opioid intracellular receptor 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADRA1A (α1A)
Beyond the preview
Go deeper on MEFFU.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MEFFU.